SynergEyes, Inc. is a leading expert in specialty contact lenses for both Normal and Irregular Corneal Conditions. The company offers a wide range of technologically-advanced contact lenses addressing various disease states. Since its inception in 2001, SynergEyes has been at the forefront of innovation, continually expanding its product portfolio. Its latest offering, SynergEyes iD, represents a significant breakthrough in contact lens design, catering to individuals with astigmatism, presbyopia, hyperopia, and myopia. Notably, these lenses are customized to each patient's unique ocular anatomy. The SynergEyes Continuum of Care for Irregular Corneas includes UltraHealth hybrid lenses for mild to moderate Keratoconus and SynergEyes VSTM scleral lenses for more advanced cases. Headquartered in the United States, SynergEyes received a significant $3.53MVenture Round investment on February 10, 2017. The company takes pride in its partnerships with independent eye care professionals, aiming to transform vision for patients with astigmatism, presbyopia, and irregular corneal conditions.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Venture Round | $3.53M | - | 10 Feb 2017 | |
Venture Round | $1.96M | - | 16 Jan 2015 | |
Venture Round | $12.00M | - | 04 Aug 2014 | |
Venture Round | $5.00M | 1 | Oxford Finance LLC | 30 Mar 2011 |
Series C | $13.30M | 6 | 09 Feb 2009 |
No recent news or press coverage available for SynergEyes, Inc..